Putnam Investments’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-44,379
Closed -$4.12M 805
2021
Q1
$4.12M Sell
44,379
-73,142
-62% -$6.8M 0.01% 540
2020
Q4
$10.5M Sell
117,521
-10,691
-8% -$958K 0.02% 361
2020
Q3
$13.2M Sell
128,212
-5,929
-4% -$613K 0.03% 291
2020
Q2
$10.6M Sell
134,141
-7,558
-5% -$598K 0.02% 316
2020
Q1
$8.2M Sell
141,699
-620
-0.4% -$35.9K 0.02% 351
2019
Q4
$7.68M Hold
142,319
0.02% 428
2019
Q3
$7.44M Sell
142,319
-4,994
-3% -$261K 0.02% 424
2019
Q2
$7.12M Hold
147,313
0.02% 440
2019
Q1
$7.44M Buy
147,313
+132
+0.1% +$6.67K 0.02% 406
2018
Q4
$8.73M Buy
147,181
+71
+0% +$4.21K 0.02% 348
2018
Q3
$9.68M Buy
147,110
+89,907
+157% +$5.92M 0.02% 397
2018
Q2
$2.89M Buy
57,203
+15,949
+39% +$805K 0.01% 642
2018
Q1
$2.17M Hold
41,254
0.01% 699
2017
Q4
$1.92M Sell
41,254
-353
-0.8% -$16.4K ﹤0.01% 760
2017
Q3
$1.68M Buy
+41,607
New +$1.68M ﹤0.01% 810
2017
Q2
Sell
-188,367
Closed -$5.47M 1160
2017
Q1
$5.47M Sell
188,367
-14,714
-7% -$427K 0.01% 556
2016
Q4
$6.67M Buy
203,081
+24,033
+13% +$789K 0.02% 490
2016
Q3
$5.65M Sell
179,048
-22,442
-11% -$708K 0.01% 533
2016
Q2
$5.67M Sell
201,490
-181,266
-47% -$5.1M 0.01% 573
2016
Q1
$13.9M Sell
382,756
-4,852
-1% -$176K 0.03% 373
2015
Q4
$15.5M Sell
387,608
-81,393
-17% -$3.26M 0.04% 351
2015
Q3
$13.4M Buy
469,001
+128
+0% +$3.65K 0.03% 382
2015
Q2
$15.4M Sell
468,873
-124,214
-21% -$4.09M 0.03% 378
2015
Q1
$17.1M Buy
593,087
+67,858
+13% +$1.95M 0.03% 378
2014
Q4
$14.3M Sell
525,229
-4,670
-0.9% -$127K 0.03% 408
2014
Q3
$11.3M Sell
529,899
-4,585
-0.9% -$97.7K 0.02% 450
2014
Q2
$12M Buy
534,484
+351,084
+191% +$7.89M 0.03% 436
2014
Q1
$4.63M Buy
+183,400
New +$4.63M 0.01% 787